Local versus central laboratory discrepancies in the determination of triple-negative breast cancer (TNBC) status in a large phase III (CIBOMA/2004-01/GEICAM/2003-11) trial assessing adjuvant capecitabine (C) maintenance therapy after standard chemotherapy (CT) in early breast cancer (EBC) patients (pts)

被引：0

作者：

Ruiz-Borrego, M.

Barrios, C. H.

Lluch, A.

Bines, J.

Segalla, J. G. M.

Ruiz, A.

Torrecillas, L.

Llombart-Cussac, A.

Torres, R.

Garcia Saenz, J. A.

Lopez Garcia-Asenjo, J. A.

Gomez, H. L.

De la Haba, J. R.

Reyes, S.

Martinez, E.

Baena, J. M.

Perez-Michell, L.

Rodriguez-Lescure, A.

Anton, A.

Martin, M.

机构：

[1] Hosp Univ Virgen Rocio, Seville, Spain

[2] PUCRS Sch Med, Porto Alegre, RS, Brazil

[3] HCU Valencia, Valencia, Spain

[4] Inst Nacl Canc Brasil, Rio De Janeiro, Brazil

[5] Hosp Amaral Carvalho, Jau, Brazil

[6] Inst Valenciano Oncol, Valencia, Spain

[7] Ctr Med 20 Novembre Issste, Mexico City, DF, Mexico

[8] Hosp Arnau Vilanova, Lleida, Spain

[9] Inst Nacl Canc, Santiago, Chile

[10] Hosp Clin San Carlos, Madrid, Spain

[11] HCU San Carlos, Madrid, Spain

[12] Inst Nacl Enfermedades Neoplas, Lima, Peru

[13] Hosp Reina Sofia, Cordoba, Spain

[14] Hosp Beneficencia Espanola, San Luis Potosi, Mexico

[15] Hosp Prov Castellon, Castellon de La Plana, Spain

[16] Hosp Puerta Mar, Cadiz, Spain

[17] Clin San Jose, Obregon, Mexico

[18] Hosp Gen Elche, Alicante, Spain

[19] HU Miguel Servet, Zaragoza, Spain

[20] Hosp Univ Gregorio Maranon, Madrid, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期

关键词：

D O I：

10.1200/jco.2011.29.15_suppl.1022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1022

引用

页数：1